Gene · 56901
Papers416
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 416
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multi-Gene Myofibroblast Framework Stratifies Prognostic and Immune Landscapes in HCC. | Curr Gene Ther | 2026 | 42393881 | PubTator, text mining | PubMed |
| BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance. | Nat Commun | 2026 | 42393054 | PubTator, text mining | PubMed |
| NDUFA4L2 acts as a mitochondrial checkpoint against ferroptosis in hypoxic clear cell renal cell carcinoma. | Cell Signal | 2026 | 42331208 | PubTator, text mining | PubMed |
| YY1/HIF-1α/NDUFA4L2 signaling axis mediates bisphenol A-induced mitochondrial dysfunction and apoptosis in human ovarian granulosa cells. | Reprod Toxicol | 2026 | 42322997 | PubTator, text mining | PubMed |
| Epigenetics of Genes Displaying High and Preferential Expression in Myoblasts. | Epigenomes | 2026 | 41892369 | PubTator, text mining | PubMed |
| A comprehensive analysis of the circRNA, miRNA, and mRNA networks reveals prognostic biomarkers for gastric cancer. | Z Gastroenterol | 2026 | 41862194 | PubTator, text mining | PubMed |
| Targeting regulated cell death pathways in lung cancer: mechanisms, therapeutic strategies, and clinical translation. | Front Immunol | 2026 | 41789093 | PubTator, text mining | PubMed |
| NDUFA4L2 regulates the progression and chemotherapy sensitivity of HNSCC by inhibiting PANoptosis. | NPJ Precis Oncol | 2026 | 41787028 | PubTator, text mining | PubMed |
| Cornus officinalis Fruit Extract as an AMPK-Associated Mitochondrial Bioenergetic Modulator in Skin Aging Models. | Biomedicines | 2026 | 41751302 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Genes Associated with Autophagy and Metabolic Reprogramming in Atrial Fibrillation. | J Cardiovasc Dev Dis | 2026 | 41745330 | PubTator, text mining | PubMed |
| Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance. | Cancer Pathog Ther | 2026 | 41732210 | PubTator, text mining | PubMed |
| Neutrophils in the hepatocellular carcinoma microenvironment: orchestrators of progression and immunity. | Front Immunol | 2026 | 41710884 | PubTator, text mining | PubMed |
| Tissue-Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma. | J Extracell Vesicles | 2026 | 41656939 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis of prognostic model and immune microenvironment in intrahepatic cholangiocarcinoma. | Transl Oncol | 2026 | 41558145 | PubTator, text mining | PubMed |
| <p>Regulatory networks of HIFs in tumor‑infiltrating immune cells: From molecular mechanisms to therapeutic implications (Review)</p>. | Int J Oncol | 2026 | 41543185 | PubTator, text mining | PubMed |
| Novel insights into meningioma brain invasion with spatial transcriptomic profiling. | Acta Neuropathol Commun | 2026 | 41486296 | PubTator, text mining | PubMed |
| COA6 deficiency inhibits hepatocellular carcinoma progression by regulating cuproptosis through the JAK/STAT signaling pathway. | Biochim Biophys Acta Mol Cell Res | 2026 | 41015250 | PubTator, text mining | PubMed |
| Molecular architecture of mesoderm cells across early to middle stage of human embryo development at single-cell resolution. | BMC Mol Cell Biol | 2025 | 41449385 | PubTator, text mining | PubMed |
| Decoding dental mesenchymal stem cells diversity: single-cell transcriptomics maps heterogeneity in molar development. | Front Cell Dev Biol | 2025 | 41445584 | PubTator, text mining | PubMed |
| SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation. | Nat Commun | 2025 | 41372157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56901/papers